Showing results (1-10 of 42) with videos related to
Sort By:
Pageof 5
Discovery Medicine|September 26, 2024
Current and Emerging Immunotherapies for Systemic AL AmyloidosisValeria Moreno, Ludovic Saba, Sara Tama-Shekan, et al.Hematology Reports|September 23, 2024
How We Treat Hemolytic Anemia Due to Pyruvate Kinase DeficiencySara Tama-Shekan, Valeria Moreno, Ludovic Saba, et al.Clinical Lymphoma, Myeloma & Leukemia|November 10, 2024
A Real-World Analysis on Access to Triplet and Quadruplet Therapy in Newly Diagnosed Multiple Myeloma Patients in the United StatesLudovic Saba, Chieh-Lin Fu, Hong Liang, et al.Oncology (Williston Park, N.Y.)|October 25, 2023
Secondary Pure Red Cell Aplasia During Daratumumab/ Hyaluronidase Therapy for Multiple MyelomaLudovic Saba, Kevin S Landau, Silvia Bunting, et al.Cancer Medicine|March 3, 2026
Comparative Outcomes Between Black and White Patients With Early-Stage Diffuse Large B-Cell LymphomaMaría Herrán, Sindu Iska, Hong Liang, et al.American Journal of Hematology|April 11, 2024
Evaluating ChatGPT as an educational resource for patients with multiple myeloma: A preliminary investigationLudovic Saba, Chieh-Lin Fu, Jack Khouri, et al.American Journal of Clinical Oncology|March 25, 2026
Clinical Features, Treatment Patterns, and Outcomes of Solitary Plasmacytoma in the United States: A National Cancer Database (NCDB) Analysis of Years 2004 to 2020Ludovic Saba, Gaelle C Haddad, John Greskovich, et al.Cancers|August 12, 2022
A Synopsis Clonal Hematopoiesis of Indeterminate Potential in HematologyMaroun Bou Zerdan, Lewis Nasr, Ludovic Saba, et al.International Journal of Hematologic Oncology|June 6, 2022
Adhesion molecules in multiple myeloma oncogenesis and targeted therapyMaroun Bou Zerdan, Lewis Nasr, Joseph Kassab, et al.Current Hematologic Malignancy Reports|September 13, 2013
New insights and modern treatment of AL amyloidosisChakra P Chaulagain, Raymond L ComenzoPageof 5